Discovery of novel melatonin–mydroxyquinoline hybrids as multitarget strategies for Alzheimer’s disease therapy
Alzheimer’s disease (AD) is a neurodegenerative disease that seriously affects human health, and current treatment strategies are far from meeting clinical needs. Inspired by multi-target drug design strategies, a series of novel natural products-based melatonin–hydroxyquinoline hybrids were designe...
שמור ב:
| Principais autores: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Frontiers Media S.A.
2024-04-01
|
| סדרה: | Frontiers in Chemistry |
| נושאים: | |
| גישה מקוונת: | https://www.frontiersin.org/articles/10.3389/fchem.2024.1374930/full |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|